Flunisolide Acetate

Flunisolide Acetate

SCHEMBL11318982

CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 9/20 0.81
▸ NR3C1 P04150 7/20 0.81
▸ CYP3A4 P08684 6/20 0.81
▸ LMNA P02545 5/20 0.81
▸ ABCB11 O95342 3/20 0.81
▸ KDM4E B2RXH2 2/20 0.81
▸ HSD17B10 Q99714 2/20 0.81
▸ CYP2C19 P33261 1/20 0.81
▸ HTR1A P08908 1/20 0.81
▸ ADRA2A P08913 1/20 0.81
▸ ADRA1A P35348 1/20 0.81
▸ HIF1A Q16665 6/20 0.66
▸ AR P10275 5/20 0.66
▸ ALDH1A1 P00352 1/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ NPSR1 Q6W5P4 2/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ F2 P00734 1/20 0.54
▸ MAPT P10636 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flunisolide Acetate SCHEMBL11439896 1.00 PGR (0.81) PGRNR3C1CYP3A4LMNAABCB11
Flunisolide Acetate SCHEMBL22171521 1.00 PGR (0.81) PGRNR3C1CYP3A4LMNAABCB11
Flunisolide Acetate SCHEMBL29647928 1.00 PGR (0.81) PGRNR3C1CYP3A4LMNAABCB11
SCHEMBL13368106 0.92 PGR (0.83) PGRNR3C1CYP3A4LMNAABCB11
SCHEMBL13491387 0.92 PGR (0.83) PGRNR3C1CYP3A4LMNAABCB11
SCHEMBL13181587 0.90 PGR (0.80) PGRNR3C1CYP3A4LMNAABCB11
SCHEMBL13491146 0.90 PGR (0.80) PGRNR3C1CYP3A4LMNAABCB11
SCHEMBL11865029 0.90 PGR (0.80) PGRNR3C1CYP3A4LMNAABCB11
SCHEMBL13341447 0.90 PGR (0.80) PGRNR3C1CYP3A4LMNAABCB11
SCHEMBL13595541 0.90 PGR (0.80) PGRNR3C1CYP3A4LMNAABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108135863-B EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions 特拉维夫医疗中心医学研究基础设施和保健服务基金会 2021-07-27 — — CN disclosed
US-10538551-B2 Process for preparation of corticosteroids CORAL DRUGS PVT. LTD. (IN) 2020-01-21 — — US disclosed
CN-110678543-A In vitro culture system and method of use 耶达研究及发展有限公司 2020-01-10 — — CN disclosed
US-20190177361-A1 NOVEL PROCESS FOR PREPARATION OF CORTICOSTEROIDS CORAL DRUGS PVT. LTD. (IN) 2019-06-13 — — US disclosed
US-10233210-B2 Process for preparation of glucocorticoid steroids CORAL DRUGS PVT. LTD. (IN) 2019-03-19 — — US disclosed
US-20180002372-A1 NOVEL PROCESS FOR PREPARATION OF GLUCOCORTICOID STEROIDS CORAL DRUGS PVT. LTD. (IN) 2018-01-04 — — US disclosed
US-4305936-A SOLUBILIZERS CONSISTING OF FATTY ACID GLYCERIDES, COCAMIDOPROPYL BETAINE AND A GLYCOL DERMIK LABORATORIES (US) 1981-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10538551-B2 Process for preparation of corticosteroids HSD17B7, NR3C2, CYP21A2 PGR 56/4885NR3C1 17/4885CYP3A4 99/4885
US-20190177361-A1 NOVEL PROCESS FOR PREPARATION OF CORTICOSTEROIDS HSD17B7, NR3C2, CYP11B1 PGR 53/4885NR3C1 18/4885CYP3A4 96/4885
US-10233210-B2 Process for preparation of glucocorticoid steroids CYP21A2, NR3C2, NR3C1 PGR 65/4885NR3C1 3/4885CYP3A4 52/4885
US-20180002372-A1 NOVEL PROCESS FOR PREPARATION OF GLUCOCORTICOID STEROIDS NR3C2, NR3C1, CYP21A2 PGR 64/4885NR3C1 2/4885CYP3A4 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback